Home›Articles›What the phase I pancreatic cancer trial of autogene cevumeran tested and foundArticleWhat the phase I pancreatic cancer trial of autogene cevumeran tested and foundArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnAutogene cevumeran, Drugs and Medicinal Substances Well-attested SourcesPersonalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer (Nature, 2023)AbstractQuote, Abstractinduced de novo high-magnitude neoantigen-specific T cells in 8 out of 16 patientsView the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.